BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12647444)

  • 1. [Olanzapine in the first episode of schizophrenia in young adults].
    Dabkowska M
    Psychiatr Pol; 2002; 36(6 Suppl):235-41. PubMed ID: 12647444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Safety and efficacy of olanzapine versus perphenazine in patients with schizophrenia: results of multicenter, 18-week, double-blind clinical trial].
    Jarema M; Olajossy M; Chrzanowski W; Araszkiewicz A; Landowski J; Rybakowski J; Bilikiewicz A; Bomba J; Debowska G
    Psychiatr Pol; 2003; 37(4):641-55. PubMed ID: 14560493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effectiveness of risperidone and olanzapine in resistant or intolerant schizophrenic patients. A mirror study.
    Søholm B; Lublin H
    Acta Psychiatr Scand; 2003 May; 107(5):344-50. PubMed ID: 12752030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential olanzapine plasma concentrations by sex in a fixed-dose study.
    Kelly DL; Conley RR; Tamminga CA
    Schizophr Res; 1999 Nov; 40(2):101-4. PubMed ID: 10593449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine. Keep an eye on this neuroleptic.
    Can Fam Physician; 2000 Feb; 46():322-6, 330-6. PubMed ID: 10690489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics and cognition in schizophrenia.
    Sharma T
    Arch Gen Psychiatry; 2002 Jun; 59(6):571-2; author reply 573-5. PubMed ID: 12044209
    [No Abstract]   [Full Text] [Related]  

  • 7. Olanzapine-induced retarded ejaculation: role of paroxetine comedication? A case report.
    Bizouard P; Vandel S; Kantelip JP
    Therapie; 2001; 56(4):443-5. PubMed ID: 11677871
    [No Abstract]   [Full Text] [Related]  

  • 8. Olanzapine augmentation of fluoxetine in the treatment of refractory obsessive-compulsive disorder.
    Potenza MN; Wasylink S; Longhurst JG; Epperson CN; McDougle CJ
    J Clin Psychopharmacol; 1998 Oct; 18(5):423-4. PubMed ID: 9790164
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid resolution of antipsychotic-induced tardive dyskinesia with olanzapine.
    Khan M; Farver D
    S D J Med; 2000 Feb; 53(2):65-7. PubMed ID: 10731859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose olanzapine therapy in schizophrenia.
    Alao AO; Armenta WA; Yolles JC
    Ann Pharmacother; 1999 Nov; 33(11):1228. PubMed ID: 10573326
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of clozapine and olanzapine: a comparison in severe, psychotically ill patients.
    Di Lorenzo R; Tondelli G; Genedani S
    Int J Neuropsychopharmacol; 2001 Jun; 4(2):135-7. PubMed ID: 11466163
    [No Abstract]   [Full Text] [Related]  

  • 12. Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study.
    Francobandiera G
    Can J Psychiatry; 2001 May; 46(4):356-8. PubMed ID: 11387793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine in the treatment-resistant, combat-related PTSD--a series of case reports.
    Jakovljević M; Sagud M; Mihaljević-Peles A
    Acta Psychiatr Scand; 2003 May; 107(5):394-6; discussion 396. PubMed ID: 12752037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching from depot antipsychotic drugs to olanzapine in patients with chronic schizophrenia.
    Godleski LS; Goldsmith LJ; Vieweg WV; Zettwoch NC; Stikovac DM; Lewis SJ
    J Clin Psychiatry; 2003 Feb; 64(2):119-22. PubMed ID: 12633119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosing the antipsychotic medication olanzapine.
    Nemeroff CB
    J Clin Psychiatry; 1997; 58 Suppl 10():45-9. PubMed ID: 9265916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.
    Breier A; Meehan K; Birkett M; David S; Ferchland I; Sutton V; Taylor CC; Palmer R; Dossenbach M; Kiesler G; Brook S; Wright P
    Arch Gen Psychiatry; 2002 May; 59(5):441-8. PubMed ID: 11982448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia.
    Martín J; Gómez JC; García-Bernardo E; Cuesta M; Alvarez E; Gurpegui M
    J Clin Psychiatry; 1997 Nov; 58(11):479-83. PubMed ID: 9413413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine-induced reversible priaprism: a case report.
    Deirmenjian JM; Erhart SM; Wirshing DA; Spellberg BJ; Wirshing WC
    J Clin Psychopharmacol; 1998 Aug; 18(4):351-3. PubMed ID: 9690708
    [No Abstract]   [Full Text] [Related]  

  • 19. Schizophrenia and schizoaffective disorder treated with high doses of olanzapine.
    Fanous A; Lindenmayer JP
    J Clin Psychopharmacol; 1999 Jun; 19(3):275-6. PubMed ID: 10350037
    [No Abstract]   [Full Text] [Related]  

  • 20. Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition.
    Poyurovsky M; Pashinian A; Gil-Ad I; Maayan R; Schneidman M; Fuchs C; Weizman A
    Am J Psychiatry; 2002 Jun; 159(6):1058-60. PubMed ID: 12042201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.